Cargando…

The Role of B Cells in Primary Progressive Multiple Sclerosis

The success of ocrelizumab in reducing confirmed disability accumulation in primary progressive multiple sclerosis (PPMS) via CD20-targeted depletion implicates B cells as causal agents in the pathogenesis of PPMS. This review explores the possible mechanisms by which B cells contribute to disease p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holloman, Jameson P., Axtell, Robert C., Monson, Nancy L., Wu, Gregory F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215437/ https://www.ncbi.nlm.nih.gov/pubmed/34163430 http://dx.doi.org/10.3389/fneur.2021.680581

Ejemplares similares

Dual Role of B Cells in Multiple Sclerosis
por: Kumar, Gaurav, et al.
Publicado: (2023)

Deciphering Multiple Sclerosis Progression
por: Meca-Lallana, Virginia, et al.
Publicado: (2021)

Intrathecal, Not Systemic Inflammation Is Correlated With Multiple Sclerosis Severity, Especially in Progressive Multiple Sclerosis
por: Milstein, Joshua L., et al.
Publicado: (2019)

Disease activity in primary progressive multiple sclerosis: a systematic review and meta-analysis
por: Blok, Katelijn M., et al.
Publicado: (2023)

Money Management in Multiple Sclerosis: The Role of Cognitive, Motor, and Affective Factors
por: Yael, Goverover, et al.
Publicado: (2019)

Potential Impact of B Cells on T Cell Function in Multiple Sclerosis
por: Ireland, Sara, et al.
Publicado: (2011)

Vision and Vision-Related Measures in Progressive Multiple Sclerosis
por: Backner, Yael, et al.
Publicado: (2019)

Gray Matter Matters: A Longitudinal Magnetic Resonance Voxel-Based Morphometry Study of Primary Progressive Multiple Sclerosis
por: Rothstein, Ted L.
Publicado: (2020)

Emerging Role of Follicular T Helper Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: Quinn, James L., et al.
Publicado: (2018)

Consensus on early detection of disease progression in patients with multiple sclerosis
por: Meca-Lallana, José E., et al.
Publicado: (2022)

The Role of Antibodies in the Pathogenesis of Multiple Sclerosis
por: Yu, Xiaoli, et al.
Publicado: (2020)

B Cells in Multiple Sclerosis and Virus-Induced Neuroinflammation
por: Chunder, Rittika, et al.
Publicado: (2020)

Role of Family Planning in Women With Multiple Sclerosis in Switzerland: Results of the Women With Multiple Sclerosis Patient Survey
por: Kamm, Christian P., et al.
Publicado: (2018)

Sex-Specific Environmental Impacts on Initiation and Progression of Multiple Sclerosis
por: Leffler, Jonatan, et al.
Publicado: (2022)

The Role of Cerebral Hypoperfusion in Multiple Sclerosis (ROCHIMS) Trial in Multiple Sclerosis: Insights From Negative Results
por: Hostenbach, Stéphanie, et al.
Publicado: (2020)

Progression risk stratification with six-minute walk gait speed trajectory in multiple sclerosis
por: Goldman, Myla D., et al.
Publicado: (2023)

Hepatitis B Vaccine and Multiple Sclerosis: Cause or Coincidence
por: Luhadia, Kunjal, et al.
Publicado: (2022)

Dietary Therapy in Secondary Progressive Multiple Sclerosis: A Case Report
por: Nathan, Janak, et al.
Publicado: (2019)

Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis
por: Hänninen, Katariina, et al.
Publicado: (2020)

An Atypical Presentation of Progressive Multiple Sclerosis in a Young Black Male
por: Franks, Charles, et al.
Publicado: (2023)

Multiple challenges for people after transitioning to secondary progressive multiple sclerosis: a qualitative study
por: Bogosian, Angeliki, et al.
Publicado: (2019)

Validation of Quantitative Scores Derived From Motor Evoked Potentials in the Assessment of Primary Progressive Multiple Sclerosis: A Longitudinal Study
por: Hardmeier, Martin, et al.
Publicado: (2020)

Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis
por: Roach, Charles A., et al.
Publicado: (2021)

Examining the Role of Resilience and Hope in Grit in Multiple Sclerosis
por: Lee, Beatrice, et al.
Publicado: (2022)

Efficacy and Safety of Intravenous Cladribine in Patients with Rapidly Evolving or Early Secondary Progressive Multiple Sclerosis
por: Alshamrani, Foziah, et al.
Publicado: (2020)

Mapping the Progressive Treatment-Related Reduction of Active MRI Lesions in Multiple Sclerosis
por: Giorgio, Antonio, et al.
Publicado: (2020)

A Rare Case of Susac's Syndrome Masquerading as Progressive-Relapsing Multiple Sclerosis
por: Darwish, Nedal, et al.
Publicado: (2022)

Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?
por: Abdelhak, Ahmed, et al.
Publicado: (2019)

‘You are just left to get on with it’: qualitative study of patient and carer experiences of the transition to secondary progressive multiple sclerosis
por: Davies, F, et al.
Publicado: (2015)

Microglia in the context of multiple sclerosis
por: Zhang, Xue, et al.
Publicado: (2023)

Patients With Epileptic Seizures and Multiple Sclerosis in a Multiple Sclerosis Center in Southern Germany Between 2003–2015
por: Schorner, Anja, et al.
Publicado: (2019)

The Potential Role of Neurophysiology in the Management of Multiple Sclerosis-Related Fatigue
por: Capone, Fioravante, et al.
Publicado: (2020)

Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications
por: Wang, Xu, et al.
Publicado: (2022)

Cognitive and Language Deficits in Multiple Sclerosis: Comparison of Relapsing Remitting and Secondary Progressive Subtypes
por: Ntoskou, Katerina, et al.
Publicado: (2018)

Silent Free Fall at Disease Onset: A Perspective on Therapeutics for Progressive Multiple Sclerosis
por: LoPresti, Patrizia
Publicado: (2018)

Walking Training Enhances Corticospinal Excitability in Progressive Multiple Sclerosis—A Pilot Study
por: Chaves, Arthur R., et al.
Publicado: (2020)

Neurophysiological and clinical biomarkers of secondary progressive multiple sclerosis: A cross-sectional study
por: Tartaglia, Matteo, et al.
Publicado: (2023)

Comorbidity in Multiple Sclerosis
por: Magyari, Melinda, et al.
Publicado: (2020)

Editorial: Insights in multiple sclerosis and neuroimmunology: 2021
por: Weissert, Robert
Publicado: (2023)

Processing speed and memory test performance are associated with different brain region volumes in Veterans and others with progressive multiple sclerosis
por: Spain, Rebecca I., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_22qfo191o64lo4hg476i8ek2hs